AVNS Q2 2022 Earnings — Avanos Medical, Inc. Revenue & Financial Results | Market Cap Arena

AVNSAvanos Medical, Inc.

$621M

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$171M-8.3% YoY

Gross Profit

$102M59.4% margin

Operating Income

$12M6.9% margin

Net Income

$13M7.3% margin

EPS (Diluted)

$0.24

QoQ Revenue Growth

-13.4%

Cash Flow

Operating Cash Flow

$27M

Free Cash Flow

$23M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$501M

Stockholders' Equity

$1.3B

Cash & Equivalents

$107M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$171M	$186M	-8.3%
Gross Profit	$102M	$92M	+11.0%
Operating Income	$12M	$15M	-22.4%
Net Income	$13M	$38M	-67.0%

Revenue Segments

Chronic Care

$112M28%

Pain Management

$91M22%

Digestive health

$80M20%

Interventional pain

$50M12%

Acute pain

$41M10%

Respiratory health

$32M8%